Mistletoe extract reduces the surgical suppression of natural killer cell activity in cancer patients. A randomized phase III trial

Forschende Komplementarmedizin

Volumn 14, Issue 1, 2007, Pages 9-17

  Schink, M ^a,g   Troger W ^b   Dabidian, A ^c   Goyert, A ^d   Scheuerecker, H ^c   Meyer, J ^e   Fischer, I U ^f   Glaser, F ^c  

^a Forschungsabteilung   (Germany)

^b Klinische Forschung Dr Tröger   (Germany)

^c Chirurgische Abteilung   (Germany)

^d Abteilung fur Innere Medizin   (Germany)

^e Abteilung fur Anasthesie und Intensivmedizin   (Germany)

^f Buro fur Biostatistik   (Germany)

^g Verein Filderklinik eV   (Germany)

Author keywords

Colorectal cancer; HLA DR; Mistletoe; Monocytes; NK cell activity; Randomized controlled trial; Sequential analysis

Indexed keywords

HLA DR ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; VISCUM ALBUM EXTRACT;

AGED; ANASTOMOSIS LEAKAGE; ANTIGEN EXPRESSION; ARTICLE; BLISTER; BODY TEMPERATURE; CANCER PATIENT; CANCER SURGERY; CLINICAL ARTICLE; CLINICAL TRIAL; COLORECTAL CANCER; CONTROLLED CLINICAL TRIAL; FEMALE; HEMATURIA; HUMAN; HUMAN CELL; HYPERTENSION; HYPOTENSION; IMMUNE DEFICIENCY; ISCHEMIA; MALE; MATHEMATICAL COMPUTING; MONOCYTE; NATURAL KILLER CELL; PERIOPERATIVE PERIOD; PHASE 3 CLINICAL TRIAL; POSTOPERATIVE COMPLICATION; PROSPECTIVE STUDY; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SINGLE DRUG DOSE; STATISTICAL ANALYSIS; URINARY TRACT INFECTION; VISCUM ALBUM;

AGED; COLORECTAL NEOPLASMS; FEMALE; HUMANS; INFUSIONS, PARENTERAL; KILLER CELLS, NATURAL; MALE; MISTLETOE; PERIOPERATIVE CARE; PHYTOTHERAPY; PLANT EXTRACTS; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 33847657527     PISSN: 16614119     EISSN: 16614127     Source Type: Journal    
DOI: 10.1159/000098135     Document Type: Article

References (35)

1. Pollock RE, Lotzova E, Stanford SD: Surgical stress impairs natural killer cell programming of tumor for lysis in patients with sarcomas and other solid tumors. Cancer 1992;70:2192-2202.
2. Brittenden J, Heys SD, Ross J, Eremin O: Natural killer cells and cancer. Cancer 1996;77:1226-1243.
3. Ben-Eliyahu S, Page GG, Yirmiya R, Shakhar G: Evidence that stress and surgical interventions promote tumor development by suppressing natural killer cell activity. Int J Cancer 1999;80:880-888.
4. Hansen E, Wolff N, Knuechel R, Ruschoff J, Hofstaedter F, Taeger K: Tumor cells in blood shed from the surgical field. Arch Surg 1995;130:387-393.
5. Patel H, Le Marer N, Wharton RQ, Khan ZA, Araia R, Glover C, Henry MM, Allen-Mersh TG: Clearance of circulating tumor cells after excision of primary colorectal cancer. Ann Surg 2002;235:226-231.
6. Yamaguchi K, Takagi Y, Aoki S, Futamura M, Saji S: Significant detection of circulating cancer cells in the blood by reverse transcriptase-polymerase chain reaction during colorectal cancer resection. Ann Surg 2000;232:58-65.
7. Miyazono F, Natsugoe S, Takao S, Tokuda K, Kijima F, Aridome K, Hokita S, Baba M, Eizuru Y, Aikou T: Surgical maneuvers enhance molecular detection of circulating tumor cells during gastric cancer surgery. Ann Surg 2001;233:189-194.
8. Brune IB, Wilke W, Hensler T, Feussner H, Holzmann B, Siewert JR: Normal T lymphocyte and monocyte function after minimally invasive surgery. Surg Endosc 1998;12:1020-1024.
9. Wakefield CH, Carey PD, Foulds S, Monson JRT, Guillou PJ: Changes in major histocompatibility complex class II expression in monocytes and T cells of patients developing infection after surgery. Br J Surg 1993;80:205-209.
10. Sietses C, Beelen RH, Meijer S, Cuesta MA: Immunological consequences of laparoscopic surgery, speculations on the cause and clinical implications. Langenbecks Arch Surg 1999;384:250-258.
11. Berg PA, Stein GM: Does mistletoe therapy influence the defense against epithelial tumors? A critical immunological analysis. Dtsch Med Wochenschr 2001;126:339-345.
12. Schink M: Mistletoe therapy for human cancer: the role of the natural killer cells. Anticancer Drugs 1997;8:S47-S51.
13. Hajto T, Lanzrein C: Natural killer and antibody-dependent cell-mediated cytotoxicity activities and large granular lymphocyte frequencies in Viscum album-treated breast cancer patients. Oncology 1986;43:93-97.
14. Hajto T, Hostanska K, Frei K, Rordorf C, Gabius HJ: Increased secretion of tumor necrosis factor α, interleukin 1, and interleukin 6 by human mononuclear cells exposed to β-galactoside-specific lectin from clinically applied mistletoe extract. Cancer Res 1986;50:3322-3326.
15. Ribéreau-Gayon G, Dumont S, Muller C, Jung ML, Poindron P, Anton R: Mistletoe lectins I, II and III induce the production of cytokines by cultured human monocytes. Cancer Lett 1996;109:33-38.
16. Büssing A, Bischof M, Hatzmann W, Bartsch F, Soto-Vera D, Fronk E-M, Gmeindl M, Stein GM: Prevention of surgery-induced suppression of granulocyte function by intravenous application of a fermented extract from Viscum album L. in breast cancer patients. Anticancer Res 2005;25:4753-4758.
17. Korzeniewski C, Callewaert DM: An enzyme-release assay for natural cytotoxicity. J Immunol Meth 1983;64:313-320.
18. Whitehead J: The Design and Analysis of Sequential Clinical Trails, ed 2. Chichester, Ellis Horwood, 1992.
19. Vallejo R, Hord ED, Barna SA, Santiago-Palma J, Ahmed S: Perioperative immunosuppression in cancer patients. J Environ Pathol Toxicol Oncol 2003;22:139-146.
20. Long EO: Tumor cell recognition by natural killer cells. Semin Cancer Biol 2002;12:57-61.
21. Aboud M, Kingsmore S, Segal S: Role of natural killer cells in controlling local tumor formation and metastatic manifestation of different 3LL Lewis lung carcinoma cell clones. Nat Immun 1993;12:17-24.
22. Kondo E, Koda K, Takiguchi N, Oda K, Seike K, Ishizuka M, Miyazaki M: Preoperative natural killer cell activity as a prognostic factor for distant metastasis following surgery for colon cancer. Dig Surg 2003;20:445-451.
23. Pross HF, Lotzova E: Role of natural killer cells in cancer. Nat Immun 1993;12:279-292.
24. Tartter PI, Steinberg B, Barron DM, Martinelli G: The prognostic significance of natural killer cell cytotoxicity in patients with colorectal cancer. Arch Surg 1987;122:1264-1268.
25. Garzetti GG, Ciavattini A, Muzzioli M, Goteri G, Mannello B, Romanini C, Fabris N: Natural killer cell activity in patients with invasive cervical carcinoma: Importance of a longitudinal evaluation in follow-up. Gynecol Obstet Invest 1995;40:133-138.
26. Arai S, Klingemann HG: Natural killer: can they be useful as adoptive immunotherapy for cancer? Expert Opin Biol Ther 2005;5:163-172.
27. Nichols PH, Ramsden CW, Ward U, Sedman PC, Primrose JN: Perioperative immunotherapy with recombinant Interleukin 2 in patients undergoing surgery for colorectal cancer. Cancer Res 1992;52:5765-5769.
28. Houvenaeghel G, Bladou F, Blache JL, Olive D, Monges G, Jacquemier J, Chandet H, Delpero JR, Guerinel G: Tolerance and feasibility of perioperative treatment with Interferon-alpha 2a in advanced cancers. Int Surg 1997;82:165-169.
29. Khan AL, Richardson S, Drew J, Larsen F, Campbell M, Heys SD, Ah-See AK, Eremin O: Polyadenylic-polyuridylic acid enhances the natural cell-mediated cytotoxicity in patients with breast cancer undergoing mastectomy. Surgery 1995;118:531-538.
30. Kolsen-Petersen JA, Nielsen JO, Tonnesen EM: Effect of hypertonic saline infusion on postoperative cellular immune function. Anesthesiology 2004;100:1108-1118.
31. Hamano K, Gohra H, Katoh T, Fujimura Y, Zempo N, Esate K: The preoperative administration of lentinan ameliorated the impairment of natural killer activity after cardiopulmonary bypass. Int J Immunopharmacol 1999;21:531-540.
32. Enesel MB, Acalovschi I, Grosu V, Sbarcea A, Rusu C, Dobre A, Weiss T, Zarkovic N: Perioperative application of the Viscum album extract Isorel in digestive tract cancer patients. Anticancer Res 2005;25:4583-4590.
33. Johnston RB: Current concepts: Immunology. Monocytes and macrophages. N Engl J Med 1988;318:747-752.
34. Gordon S: Alternative activation of macrophages. Nat Rev Immunol 2003;3:23-35.
35. Espi A, Arenas J, Garcia-Granero E, Marti E, Lledo S: Relationship of curative surgery on natural killer cell activity in colorectal cancer. Dis Colon Rectum 1996;39:429-434.